Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Frank W. Falkenberg | M | - |
CyTuVax BV
 CyTuVax BV Pharmaceuticals: MajorHealth Technology CyTuVax BV develops vaccinations for cancer treatment. Its vaccination technology includes an adjuvant composed of depot-bound cytokines acting as immune response modifiers. The firm also provides adjuvant technology licensing services. The company was founded by René Vleugels and Frank W. Falkenberg in 2011 and is headquartered in Maastricht, the Netherlands. | 13 years |
See more
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jos A. G. Nijhuis | M | 59 |
Radboud University Nijmegen
| 5 years |
| Marnix A. Snijder | M | 78 |
Radboud University Nijmegen
| 8 years |
| Christiaan Holland | M | - |
Radboud University Nijmegen
| 1 years |
| Jack A. Schalken | M | - |
Radboud University Nijmegen
| 3 years |
| Steve Klink | M | - |
Radboud University Nijmegen
| 6 years |
| Wiebe Olijve | M | - |
Radboud University Nijmegen
| 23 years |
| Gus Berkhout | M | - |
Radboud University Nijmegen
| 6 years |
| Freek T.A.M. Welling | M | - |
Radboud University Nijmegen
| 6 years |
| Patrick van Berkel | M | 55 |
Radboud University Nijmegen
| 4 years |
| Willem de Geus | M | 58 |
Radboud University Nijmegen
| 4 years |
| Chisalita Dumitru | M | 50 |
Radboud University Nijmegen
| 2 years |
| Ilona Wagenaar | F | - |
Radboud University Nijmegen
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Netherlands | 13 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- René Vleugels
- Personal Network
